Chemours (NYSE: CC) reported Q2 EPS of $0.18, $0.08 better than the analyst estimate of $0.10. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.09 billion.

Outlook:

Vergnano concluded: "The first half of 2020 has been one of the most difficult periods in our short history. I am proud of the way Chemours has responded and our ability to focus and execute through these uncertain times. The outlook for the second half, while improving, remains unclear. Looking ahead, as we navigate this uncertain time, we remain focused on the execution of our short-term response plan and long-term strategy. The Chemours Team will continue to work in strong partnership with our customers to deliver the full potential of our value proposition, because we win only if our customers win."

For earnings history and earnings-related data on Chemours (CC) click here.